Brief Introduction

Nanjing Vishee Medical Technology Co., Ltd. was founded in 2001, mainly engaged in the R&D, production and sales of rehabilitation medical equipment and products, dedicated to the Pelvic Floor Rehabilitation, Postpartum Rehabilitation, Neurological Rehabilitation, Psychiatric Rehabilitation and other areas to provide safe and effective rehabilitation products and solutions for medical and professional institutions. At present, the main products of the company are electrical stimulation, magnetic stimulation, Electrophysiological equipment, consumables and accessories,etc.

The company's products have been widely used in more than 6000 medical and professional institutions in China. From 2017 to 2019, the average annual compound growth rate of operating revenue and net profit were 48.55% and 56.86% respectively, ranking the top among the rehabilitation equipment enterprises in China that have publicly disclosed their operating data in terms of revenue scale.

The Company is conducting R&D of new products such as next-generation magnetic stimulator and rehabilitation robot and will continue to align itself with the technological development direction of international leading enterprises in each segment, continuously achieve technological breakthroughs, speed up the transformation of the Company's advanced technologies, further enhance the market competitiveness of the Company's products and strive to develop into a leading rehabilitation medical equipment company in the future.

Company Overview

Full name Nanjing Vishee Medical Technology Co., Ltd.
Abbreviations VISHEE
Code 688580
Founded January 10, 2001
Listing July 21, 2020
Domicile Nanjing
STAR Theme Biomedicine
CSRCSector Manufacturing
Has weighted voting rights structure? No



  2019 2018 2017
Earnings Per Share(Yuan) 1.95 1.24 0.80
R&D expenditure as a % of operating revenue 8.59% 8.92% 9.03%
Operating Revenue(Yuan) 318,873,166.20 207,781,492.42 144,495,129.73
Net Income(Yuan) 98,890,929.61 62,724,876.50 40,189,999.30

Income Statement (Unit: RMB mn)

  2019 2018 2017
Operating Revenue 318.87 207.78 144.50
Operating Costs 83.82 53.68 37.88
Operating Income 114.67 72.02 46.85
Pretax Income 114.80 73.36 46.74
Income Tax 15.91 10.64 6.55
Net Income 98.89 62.72 40.19

Balance Sheet(Unit: RMB mn)

  2019 2018 2017
Current Assets-Total 282.31 185.42 153.12
Non-current Assets-Total 121.91 122.94 93.45
Total Assets 404.22 308.36 246.57
Current Liabilities-Total 141.64 94.51 71.31
Non-current Liabilities-Total 7.72 17.69 21.84
Total Liabilities 149.35 112.20 93.15
Stockholder's Equity
Share Capital 51.26 51.26 51.26
Retained Profits 178.69 116.80 73.43
Total Owners' Equity 254.86 196.16 153.42

Cash Flow Statement (Unit: RMB mn)

  2019 2018 2017
Net Cash Flows-Operating 141.47 85.84 52.35
Net Cash Flows-Investing -16.90 -37.55 -12.69
Net Cash Flows-Financing -42.45 -21.49 2.26

Top 10 Shareholders

Name No. of Shares Held (mn) % of Shares Held
ZhiyuWang 26.96 39.45%
PingHu 11.23 16.43%
Nanjing Zhida Investment Management Consulting Center Ltd., Part 5.67 8.29%
Shenzhen Yanghe Biomedicine Industry Investment Co.,Ltd 3.51 5.13%
Nanjing Zhimingda Enterprise Management Consulting Center Ltd., Part 1.26 1.84%
ZhanZhang 1.00 1.46%
Changjiang Securities Innovation Investment Co., Ltd 0.68 1.00%
QingmingLian 0.45 0.66%
CailongSu 0.44 0.65%
XiaomingLi 0.17 0.25%

Legal Statement

All information contained herein is provided by the underlying company itself and is for informational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular security or an overall investment strategy. The Shanghai Stock Exchange does not guarantee its accuracy and reliability and shall under no circumstance be responsible or liable for any error or for any loss directly or indirectly arising from any inaccuracy or omission or from any decision, action or non-action based on or in reliance upon the information herein.

Users may view and download the information herein for personal and non-commercial use free of charge subject to the laws of the People's Republic of China and the Legal Statement. No part of the information herein may be copied, downloaded, stored in a retrieval system or transmitted in any form or by any means, rented, displayed, performed, reproduced, photocopied, altered, sold, broadcast, published or otherwise in whole or in part in any manner for commercial purposes, without the prior written consent of the Shanghai Stock Exchange.

Users are hereby reminded that the Legal Statement represents your legally binding agreement with the Shanghai Stock Exchange. By accessing or using this website, you are also signifying your agreement with and acceptance of all the contents in the Legal Statement. The Shanghai Stock Exchange reserves the right to amend and interpret the Legal Statement.